Conditions: Glaucoma Ocular Hypertension
Keywords: Glaucoma Ocular hypertension
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 104
Healthy volunteers: no

Brief summary:
The purpose of this study is evaluate effects of TRAVATAN® versus LUMIGAN® on intraocular pressure (IOP) and ocular surface and inflammatory biomarkers.

Detailed description:

Arms:
arm 1: Travoprost 0.004% ophthalmic solution with Polyquad®, 1 drop to the study eye(s), once a day in the evening, for 6 months arm 2: Bimatoprost 0.01% ophthalmic solution with BAK, 1 drop to the study eye(s), once a day in the evening, for 6 months

Interventions: intervention 1: Travoprost 0.004% ophthalmic solution intervention 2: Bimatoprost 0.01% ophthalmic solution
Intervention descriptions: intervention 1: Ophthalmic solution without benzalkonium chloride (BAK), containing Polyquad® preservative intervention 2: Ophthalmic solution containing benzalkonium chloride (BAK)

Protocol document: